{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:55:04Z","timestamp":1788044104760,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To examine the performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings compared to other patient-reported screening tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from a prospective cohort of patients discharged from general internal medicine wards from two hospitals in Edmonton, Alberta were used in this study. Two waves of measurements (discharge and 90-days post-discharge) were analyzed. The performance of the EQ-5D-3L was compared to other self-report screening tools: Generalized Anxiety Disorder 2-item questionnaire was used to categorize anxiety symptoms into absent (&lt;\u20093) and present (\u2265\u20093), and the Patient Health Questionnaire 9-items was used to categorize depressive symptoms by two severity cut-points: no (&lt;\u200910) vs. mild (\u2265\u200910), and no (&lt;\u200915) vs. moderate-severe (\u2265\u200915). Performance of EQ-5D-3L in screening for anxiety and depressive symptoms was evaluated using receiver operating curve (ROC) analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Average age of participants (n\u2009=\u2009493) was 62.9\u00a0years (SD 18.6); 51% were female. At discharge, 30.0% screened positive for mild and 12.8% for moderate-severe depressive symptoms, while 27.6% screened positive for anxiety symptoms. For co-morbid symptoms, 17.1% screened positive for anxiety and any depressive symptoms, while 10.8% for anxiety and moderate-severe depressive symptoms. While the EQ-5D-3L had limited screening ability in hospital, the anxiety\/depression dimension performed well in the community setting (90-days post-discharge) in screening for anxiety (area under ROC 0.79), depressive symptoms (any: 0.78, moderate-severe: 0.84), and a combination of both (any: 0.86; moderate-severe: 0.91).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The EQ-5D-3L anxiety\/depression dimension could be a useful tool in screening for anxiety and depressive symptoms in community settings compared to other self-report screening tools. The usefulness of the EQ-5D-3L as a screening tool in other settings and populations is warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-021-01731-x","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T10:18:12Z","timestamp":1616149092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings"],"prefix":"10.1186","volume":"19","author":[{"given":"Hilary","family":"Short","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al Sayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Ohinmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-2857","authenticated-orcid":false,"given":"Jeffrey A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"issue":"3","key":"1731_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.genhosppsych.2013.12.004","volume":"36","author":"L Rayner","year":"2014","unstructured":"Rayner L, Matcham F, Hutton J, et al. Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatry. 2014;36(3):318\u201324.","journal-title":"Gen Hosp Psychiatry"},{"key":"1731_CR2","unstructured":"Mood Disorders Society of Canada. Quick facts: mental illness & addiction in Canada. 2019."},{"key":"1731_CR3","unstructured":"Mental Health Commission of Canada. Strengthening the case for investing in Canada\u2019s mental health system: economic considerations. Ottawa, ON2017."},{"issue":"9","key":"1731_CR4","first-page":"3","volume":"24","author":"A Sunderland","year":"2013","unstructured":"Sunderland A, Findlay LC. Perceived need for mental health care in Canada: results from the 2012 Canadian Community Health Survey-Mental Health. Health Rep. 2013;24(9):3\u20139.","journal-title":"Health Rep"},{"issue":"3","key":"1731_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3109\/00048679109062632","volume":"25","author":"DM Clarke","year":"1991","unstructured":"Clarke DM, Minas IH, Stuart GW. The prevalence of psychiatric morbidity in general hospital inpatients. Aust N Z J Psychiatry. 1991;25(3):322\u20139.","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"1731_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/014107688908200713","volume":"82","author":"A Seltzer","year":"1989","unstructured":"Seltzer A. Prevalence, detection and referral of psychiatric morbidity in general medical patients. J R Soc Med. 1989;82(7):410\u20132.","journal-title":"J R Soc Med"},{"key":"1731_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1192\/bjp.126.4.346","volume":"126","author":"HS Moffic","year":"1975","unstructured":"Moffic HS, Paykel ES. Depression in medical in-patients. Br J Psychiatry. 1975;126:346\u201353.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"1731_CR8","first-page":"441","volume":"82","author":"P Gous","year":"1992","unstructured":"Gous P, Gagiano CA, Weich DJ. Psychiatric disorders in internal medicine. S Afr Med J. 1992;82(6):441\u20132.","journal-title":"S Afr Med J"},{"issue":"2","key":"1731_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.12788\/jhm.2693","volume":"12","author":"WW IsHak","year":"2017","unstructured":"IsHak WW, Collison K, Danovitch I, et al. Screening for depression in hospitalized medical patients. J Hosp Med. 2017;12(2):118\u201325.","journal-title":"J Hosp Med"},{"key":"1731_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2381468318799361","author":"F Al Sayah","year":"2018","unstructured":"Al Sayah F, Ohinmaa A, Johnson JA. Screening for anxiety and depressive symptoms in type 2 diabetes using patient-reported outcome measures: comparative performance of the EQ-5D-5L and SF-12v2. MDM Policy Pract. 2018. https:\/\/doi.org\/10.1177\/2381468318799361.","journal-title":"MDM Policy Pract."},{"key":"1731_CR11","unstructured":"World Health Organization. Mental health in emergencies. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/mental-health-in-emergencies. Accessed May 21, 2019."},{"issue":"2","key":"1731_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/ageing\/afr169","volume":"41","author":"M Dennis","year":"2012","unstructured":"Dennis M, Kadri A, Coffey J. Depression in older people in the general hospital: a systematic review of screening instruments. Age Ageing. 2012;41(2):148\u201354.","journal-title":"Age Ageing"},{"issue":"3","key":"1731_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/jgs.12686","volume":"62","author":"JS Albrecht","year":"2014","unstructured":"Albrecht JS, Gruber-Baldini AL, Hirshon JM, et al. Depressive symptoms and hospital readmission in older adults. J Am Geriatr Soc. 2014;62(3):495\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1731_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1477-7525-8-47","volume":"8","author":"H-H K\u00f6nig","year":"2010","unstructured":"K\u00f6nig H-H, Born A, G\u00fcnther O, et al. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health Qual Life Outcomes. 2010;8(1):47.","journal-title":"Health Qual Life Outcomes"},{"key":"1731_CR15","unstructured":"Brazier J, Connell J, Papaioannou D, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):vii-viii, xiii-xxv, 1\u2013188."},{"key":"1731_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-2-20","volume":"2","author":"C Sapin","year":"2004","unstructured":"Sapin C, Fantino B, Nowicki M-L, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes. 2004;2:20\u201320.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"1731_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11136-006-9159-z","volume":"16","author":"AL Supina","year":"2007","unstructured":"Supina AL, Johnson JA, Patten SB, Williams JV, Maxwell CJ. The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Qual Life Res. 2007;16(5):749\u201354.","journal-title":"Qual Life Res"},{"key":"1731_CR18","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.10m01013","author":"M Vermani","year":"2011","unstructured":"Vermani M, Marcus M, Katzman MA. Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study. Prim Care Companion CNS Disord. 2011. https:\/\/doi.org\/10.4088\/PCC.10m01013.","journal-title":"Prim Care Companion CNS Disord."},{"issue":"4","key":"1731_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/da.10065","volume":"16","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety. 2002;16(4):162\u201371.","journal-title":"Depress Anxiety"},{"issue":"Suppl 13","key":"1731_CR20","first-page":"20","volume":"65","author":"PP Roy-Byrne","year":"2004","unstructured":"Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65(Suppl 13):20\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1731_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/da.20149","volume":"23","author":"K Shear","year":"2006","unstructured":"Shear K, Belnap BH, Mazumdar S, Houck P, Rollman BL. Generalized anxiety disorder severity scale (GADSS): a preliminary validation study. Depress Anxiety. 2006;23(2):77\u201382.","journal-title":"Depress Anxiety"},{"issue":"19","key":"1731_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1001\/jama.1995.03530190025030","volume":"274","author":"RL Spitzer","year":"1995","unstructured":"Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995;274(19):1511\u20137.","journal-title":"JAMA"},{"issue":"3","key":"1731_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/archfami.4.3.211","volume":"4","author":"WE Broadhead","year":"1995","unstructured":"Broadhead WE, Leon AC, Weissman MM, et al. Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med. 1995;4(3):211\u20139.","journal-title":"Arch Fam Med"},{"issue":"1","key":"1731_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/1520-6394(2000)12:1<21::AID-DA3>3.0.CO;2-U","volume":"12","author":"JR McQuaid","year":"2000","unstructured":"McQuaid JR, Stein MB, McCahill M, Laffaye C, Ramel W. Use of brief psychiatric screening measures in a primary care sample. Depress Anxiety. 2000;12(1):21\u20139.","journal-title":"Depress Anxiety"},{"issue":"3","key":"1731_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0025-7125(05)70330-8","volume":"85","author":"JP Staab","year":"2001","unstructured":"Staab JP, Datto CJ, Weinrieb RM, Gariti P, Rynn M, Evans DL. Detection and diagnosis of psychiatric disorders in primary medical care settings. Med Clin N Am. 2001;85(3):579\u201396.","journal-title":"Med Clin N Am"},{"issue":"27","key":"1731_CR26","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa1003955","volume":"363","author":"WJ Katon","year":"2010","unstructured":"Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611\u201320.","journal-title":"N Engl J Med"},{"issue":"5","key":"1731_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1525-1497.2000.06219.x","volume":"15","author":"U Sambamoorthi","year":"2000","unstructured":"Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15(5):311\u201320.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1731_CR28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/archgenpsychiatry.2011.1548","volume":"69","author":"W Katon","year":"2012","unstructured":"Katon W, Russo J, Lin EH, et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry. 2012;69(5):506\u201314.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1731_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1191\/026921699671260095","volume":"13","author":"P Le Fevre","year":"1999","unstructured":"Le Fevre P, Devereux J, Smith S, Lawrie SM, Cornbleet M. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med. 1999;13(5):399\u2013407.","journal-title":"Palliat Med"},{"issue":"7","key":"1731_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.1525-1497.1997.00076.x","volume":"12","author":"MA Whooley","year":"1997","unstructured":"Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12(7):439\u201345.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"1731_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2190\/T6XY-QLQD-E6BX-M0G3","volume":"24","author":"U Halbreich","year":"1994","unstructured":"Halbreich U. Teaching normal and abnormal behavior to primary care physicians. Int J Psychiatry Med. 1994;24(2):115\u201320.","journal-title":"Int J Psychiatry Med"},{"issue":"3","key":"1731_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4088\/JCP.08m04940blu","volume":"71","author":"M Zimmerman","year":"2010","unstructured":"Zimmerman M, Galione J. Psychiatrists\u2019 and nonpsychiatrist physicians\u2019 reported use of the DSM-IV criteria for major depressive disorder. J Clin Psychiatry. 2010;71(3):235\u20138.","journal-title":"J Clin Psychiatry"},{"key":"1731_CR33","unstructured":"Anxiety and Depression Association of America. Understand the Facts: Depression: Treatment. https:\/\/adaa.org\/understanding-anxiety\/depression\/treatment. Accessed June 12, 2019."},{"issue":"11","key":"1731_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1503\/cmaj.150100","volume":"187","author":"S Kahlon","year":"2015","unstructured":"Kahlon S, Pederson J, Majumdar SR, et al. Association between frailty and 30-day outcomes after discharge from hospital. CMAJ. 2015;187(11):799\u2013804.","journal-title":"CMAJ"},{"key":"1731_CR35","volume-title":"EQ-5D-3L user guide. Basic information on how to use the EQ-5D-5L instrument","author":"R Rabin","year":"2011","unstructured":"Rabin R, Oppe M, Janssen B, Herdman M. EQ-5D-3L user guide. Basic information on how to use the EQ-5D-5L instrument. Rotterdam: EuroQol Group; 2011."},{"issue":"Suppl 1","key":"1731_CR36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10198-013-0502-3","volume":"14","author":"NJ Devlin","year":"2013","unstructured":"Devlin NJ, Krabbe PF. The development of new research methods for the valuation of EQ-5D-5L. Eur J Health Econ. 2013;14(Suppl 1):S1-3.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1731_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","volume":"54","author":"F Xie","year":"2016","unstructured":"Xie F, Pullenayegum E, Gaebel K, et al. A time trade-off-derived value set of the EQ-5D-5L for Canada. Med Care. 2016;54(1):98\u2013105.","journal-title":"Med Care"},{"issue":"5","key":"1731_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/ebm.12.5.149","volume":"12","author":"P Skapinakis","year":"2007","unstructured":"Skapinakis P. The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med. 2007;12(5):149.","journal-title":"Evid Based Med"},{"issue":"5","key":"1731_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","volume":"146","author":"K Kroenke","year":"2007","unstructured":"Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317\u201325.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1731_CR40","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1503\/cmaj.110829","volume":"184","author":"L Manea","year":"2012","unstructured":"Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184(3):E191-196.","journal-title":"CMAJ"},{"issue":"10","key":"1731_CR41","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.apmr.2012.04.019","volume":"93","author":"CH Bombardier","year":"2012","unstructured":"Bombardier CH, Kalpakjian CZ, Graves DE, Dyer JR, Tate DG, Fann JR. Validity of the Patient Health Questionnaire-9 in assessing major depressive disorder during inpatient spinal cord injury rehabilitation. Arch Phys Med Rehabil. 2012;93(10):1838\u201345.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4857","key":"1731_CR42","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285\u201393.","journal-title":"Science"},{"key":"1731_CR43","unstructured":"Stata Statistical Software: Release 14.2. StataCorp LP; 2015."},{"key":"1731_CR44","volume-title":"Self-reported population health: an international perspective based on EQ-5D","author":"B Janssen","year":"2014","unstructured":"Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht: Springer; 2014."},{"issue":"2","key":"1731_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3724\/SP.J.1263.2011.12221","volume":"9","author":"PJ Tully","year":"2012","unstructured":"Tully PJ, Baker RA. Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. J Geriatr Cardiol. 2012;9(2):197\u2013208.","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"1731_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0272989X19851049","volume":"39","author":"A Tsuchiya","year":"2019","unstructured":"Tsuchiya A, Bansback N, Hole AR, Mulhern B. Manipulating the 5 dimensions of the EuroQol instrument: the effects on self-reporting actual health and valuing hypothetical health states. Med Decis Making. 2019;39(4):379\u201392.","journal-title":"Med Decis Making"},{"key":"1731_CR47","doi-asserted-by":"publisher","first-page":"113323","DOI":"10.1016\/j.socscimed.2020.113323","volume":"265","author":"R McDonald","year":"2020","unstructured":"McDonald R, Mullett TL, Tsuchiya A. Understanding the composite dimensions of the EQ-5D: an experimental approach. Soc Sci Med. 2020;265:113323.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1731_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1590\/2237-6089-2016-0004","volume":"39","author":"CC Meneghetti","year":"2017","unstructured":"Meneghetti CC, Guidolin BL, Zimmermann PR, Sfoggia A. Screening for symptoms of anxiety and depression in patients admitted to a university hospital with acute coronary syndrome. Trends Psychiatry Psychother. 2017;39(1):12\u20138.","journal-title":"Trends Psychiatry Psychother"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-021-01731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-021-01731-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-021-01731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T10:32:11Z","timestamp":1616149931000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-021-01731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s12955-021-01731-x","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Research Ethics Board at the University of Alberta reviewed and approved survey questions and data collection protocols. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study design was approved by the Health Research Ethics Board at the University of Alberta, protecting participants\u2019 human rights, privacy, and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Fatima Al Sayah, Arto Ohinmaa, and Jeffrey Johnson are members of the EuroQol Group. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}